Large-scale testing (Phase 3)Study completedNCT02396212
What this trial is testing
Study of Efficacy and Safety of Canakinumab in Japanese Patients With SJIA
Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals 19